Manal H El-Sayed
Overview
Explore the profile of Manal H El-Sayed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
713
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dabbous H, El-Sayed M, El Assal G, Elghazaly H, Ebeid F, Sherief A, et al.
Sci Rep
. 2021 Sep;
11(1):18983.
PMID: 34537808
No abstract available.
12.
Cressey T, Abbassi M, Lallemant M, Indolfi G, Al-Nahari M, Farid S, et al.
Pediatr Infect Dis J
. 2021 Jul;
40(12):1081-1086.
PMID: 34321444
Background: Sofosbuvir (SOF)/daclatasvir (DCV) is the direct-acting antiviral regimen of choice in many low- and middle-income countries for curative treatment of chronic hepatitis C virus (HCV) infection in adults, but...
13.
El-Baraky I, Abbassi M, Ebeid F, Hassany M, Sabry N, El-Sayed M
Clin Res Hepatol Gastroenterol
. 2021 Jun;
45(5):101747.
PMID: 34186262
Background: Hepatitis C virus (HCV) infected adolescents with beta-thalassemia major (BTM) are considered a potential population for HCV micro-elimination model development where BTM may negatively impact the pharmacokinetic exposure parameters...
14.
Mostafa A, El-Sayed M, El-Meteini M, Saleh A, Omar A, Mansour O, et al.
BMC Public Health
. 2021 Jun;
21(1):1243.
PMID: 34182960
Background: Smoking negatively impacts COVID-19 severity and adverse outcomes. Evidence on whether smoking is associated with SARS-Co-V2 infection and having a positive test is scarce, particularly from low-and middle-income countries,...
15.
Abdallah M, Alboraie M, Abdel-Razek W, Hassany M, Ammar I, Kamal E, et al.
Liver Int
. 2021 Apr;
41(7):1494-1497.
PMID: 33905164
We aimed to assess the pregnancy outcome in women with chronic HCV who had negative pregnancy test prior to the anti-HCV course and had unintended pregnancy while on HCV treatment....
16.
Dabbous H, El-Sayed M, El Assal G, Elghazaly H, Ebeid F, Sherief A, et al.
Sci Rep
. 2021 Apr;
11(1):7282.
PMID: 33790308
Favipiravir is considered a potential treatment for COVID-19 due its efficacy against different viral infections. We aimed to explore the safety and efficacy of favipiravir in treatment of COVID-19 mild...
17.
Metwally A, Elmosalami D, Elhariri H, El Etreby L, Aboulghate A, El-Sonbaty M, et al.
PLoS One
. 2021 Feb;
16(2):e0242257.
PMID: 33621232
Aim Of The Work: This study aimed at assessing the dominance of risk practices associated with HCV endemicity in Egypt and detecting the behavioral development level concerning different aspects of...
18.
Abdel Monem M, Farid S, Abbassi M, Youssry I, Andraues N, Hassany M, et al.
Int J Clin Pract
. 2021 Feb;
75(6):e14104.
PMID: 33617679
Background: Iron overload-induced oxidative stress and transfusion-acquired hepatitis C virus (HCV) infection are the main reasons of liver damage in beta thalassemia major (β-TM). Objectives: Based on metformin's hepatic benefits...
19.
Dabbous H, Abd-Elsalam S, El-Sayed M, Sherief A, Ebeid F, Abd El Ghafar M, et al.
Arch Virol
. 2021 Jan;
166(3):949-954.
PMID: 33492523
No specific antiviral drugs have been approved for the treatment of COVID-19. This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter randomized...
20.
Mostafa A, Kandil S, El-Sayed M, Girgis S, Hafez H, Yosef M, et al.
Int J Infect Dis
. 2021 Jan;
104:534-542.
PMID: 33484863
Background: We examined Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) seroconversion incidence and risk factors 21 days after baseline screening among healthcare workers (HCWs) in a resource-limited setting. Methods: A...